Matlow A, Low D, Paret G, Jarrett S, Bohn D, Barker G
Can J Infect Dis. 2012; 3(4):189-92.
PMID: 22514369
PMC: 3328041.
DOI: 10.1155/1992/370326.
Yano H, Suetake M, Kuga A, IRINODA K, Okamoto R, Kobayashi T
J Clin Microbiol. 2000; 38(2):625-9.
PMID: 10655357
PMC: 86161.
DOI: 10.1128/JCM.38.2.625-629.2000.
McGregor K, Chang B, Mee B, Riley T
Eur J Clin Microbiol Infect Dis. 1998; 17(4):219-34.
PMID: 9707304
DOI: 10.1007/BF01699978.
Walker E, Preston R, Post J, Ehrlich G, Kalbfleisch J, Klingman K
J Clin Microbiol. 1998; 36(7):1977-83.
PMID: 9650948
PMC: 104964.
DOI: 10.1128/JCM.36.7.1977-1983.1998.
Murphy T
Microbiol Rev. 1996; 60(2):267-79.
PMID: 8801433
PMC: 239443.
DOI: 10.1128/mr.60.2.267-279.1996.
Epidemiological typing of Moraxella catarrhalis by using DNA probes.
Beaulieu D, Scriver S, Bergeron M, Low D, Parr Jr T, Patterson J
J Clin Microbiol. 1993; 31(3):736-9.
PMID: 8096219
PMC: 262859.
DOI: 10.1128/jcm.31.3.736-739.1993.
Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.
Sehgal S, al Shaimy I
Infection. 1994; 22(3):193-6.
PMID: 7927815
DOI: 10.1007/BF01716701.
Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.
McLeod D, Ahmad F, Croughan M, CALDER M
Drugs. 1986; 31 Suppl 3:109-12.
PMID: 3732080
DOI: 10.2165/00003495-198600313-00023.
The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
CALDER M, Croughan M, McLeod D, Ahmad F
Drugs. 1986; 31 Suppl 3:11-6.
PMID: 3488189
DOI: 10.2165/00003495-198600313-00005.
Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.
Vaneechoutte M, Verschraegen G, Claeys G, Van den Abeele A
J Clin Microbiol. 1988; 26(12):2544-8.
PMID: 3147992
PMC: 266942.
DOI: 10.1128/jcm.26.12.2544-2548.1988.
Increase in bronchopulmonary infection due to branhamella catarrhalis.
McLeod D, Ahmad F, Capewell S, Croughan M, CALDER M, Seaton A
Br Med J (Clin Res Ed). 1986; 292(6528):1103-5.
PMID: 3084017
PMC: 1340037.
DOI: 10.1136/bmj.292.6528.1103.
Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection.
Picard B, GOULLET P, Denamur E, Suermondt G
Epidemiol Infect. 1989; 103(3):547-54.
PMID: 2514110
PMC: 2249548.
DOI: 10.1017/s0950268800030946.
Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis.
Patterson J, Patterson T, Farrel P, Hierholzer Jr W, Zervos M
J Clin Microbiol. 1989; 27(5):944-6.
PMID: 2501355
PMC: 267459.
DOI: 10.1128/jcm.27.5.944-946.1989.
Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.
Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van den Abeele A
J Clin Microbiol. 1990; 28(12):2674-80.
PMID: 2126266
PMC: 268254.
DOI: 10.1128/jcm.28.12.2674-2680.1990.
Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens.
Vaneechoutte M, Verschraegen G, Claeys G, Van den Abeele A
J Clin Microbiol. 1990; 28(2):182-7.
PMID: 2107197
PMC: 269572.
DOI: 10.1128/jcm.28.2.182-187.1990.
Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection.
Morgan M, McKenzie H, Enright M, Bain M, Emmanuel F
Eur J Clin Microbiol Infect Dis. 1992; 11(4):305-12.
PMID: 1396749
DOI: 10.1007/BF01962069.